Great Novel Therapeutics Biotech & Medicals (TPEX:7427)

TPEX:7427 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	187.57	155.06	179.55	111.08	62.79	67.02
Short-Term Investments	313	427.7	297	136.5	62.32	-
Cash & Short-Term Investments	500.57	582.76	476.55	247.58	125.1	67.02
Cash Growth	-18.23%	22.29%	92.48%	97.90%	86.65%	74.65%
Accounts Receivable	0.25	0.72	0.09	-	-	-
Other Receivables	0.39	0.67	0.47	0.1	0.07	-
Receivables	0.63	1.39	0.56	0.1	0.07	-
Inventory	2.95	3.01	6.16	-	-	-
Prepaid Expenses	20.74	1.99	0.38	0.76	0.01	-
Other Current Assets	0.66	9.55	1.8	3.01	0.22	0.14
Total Current Assets	525.55	598.7	485.45	251.45	125.41	67.16
Property, Plant & Equipment	11.62	13.63	16.01	0.12	0.12	0.81
Other Intangible Assets	26.05	27.53	29.16	15.27	88.6	48.24
Long-Term Deferred Charges	-	1.21	6.96	5.94	3.5	-
Other Long-Term Assets	23.95	21.52	23.67	15.92	12.34	9.65
Total Assets	587.17	662.6	561.25	288.71	229.96	125.85
Accounts Payable	0.32	0.11	0.62	0.83	0.86	0.08
Accrued Expenses	-	17.6	10.05	10.63	20.42	4.92
Current Portion of Leases	2.93	2.9	2.87	-	-	-
Other Current Liabilities	14.08	1.22	2.39	0.59	0.33	0.31
Total Current Liabilities	17.34	21.82	15.93	12.05	21.61	5.3
Long-Term Leases	5.98	7.45	10.88	-	-	-
Total Liabilities	23.32	29.28	26.81	12.05	21.61	5.3
Common Stock	436.44	436.44	383.58	292.87	225.75	185.75
Additional Paid-In Capital	747.36	742.07	591.12	363.05	221.94	138.28
Retained Earnings	-589.97	-545.18	-440.26	-379.26	-239.34	-203.48
Shareholders' Equity	563.86	633.32	534.44	276.66	208.36	120.55
Total Liabilities & Equity	587.17	662.6	561.25	288.71	229.96	125.85
Total Debt	8.91	10.36	13.75	-	-	-
Net Cash (Debt)	491.66	572.4	462.8	247.58	125.1	67.02
Net Cash Growth	-18.11%	23.68%	86.93%	97.90%	86.65%	74.65%
Net Cash Per Share	11.33	13.89	12.76	10.25	5.93	4.23
Filing Date Shares Outstanding	43.06	43.64	38.36	29.29	22.57	18.58
Total Common Shares Outstanding	43.06	43.64	38.36	29.29	22.57	18.58
Working Capital	508.21	576.87	469.52	239.41	103.8	61.86
Book Value Per Share	13.09	14.51	13.93	9.45	9.23	6.49
Tangible Book Value	537.81	605.79	505.28	261.39	119.75	72.31
Tangible Book Value Per Share	12.49	13.88	13.17	8.93	5.30	3.89
Machinery	-	7.63	5.69	3.2	3.21	3.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.